Azomax capsule and film-coated caplet are indicated for the treatment of mild and moderate infection, caused by susceptible strain of the designed microorganisms in the specific conditions listed below:
Lower respiratory tract infection
Acute bacterial exacerbations of chronic obstructive pulmonary disease due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumonia. Mild to severe community-acquired pneumonia caused by Streptococcus pneumonia or Haemophilus influenza, in outpatients appropriate for oral therapy.
Upper respiratory tract infection
As an alternative to first-line therapy of acute pharyngitis/tonsillitis caused by Streptococcus pyogenes occurring in individuals who cannot use first-line therapy.
Skin and skin structure infections
Azithromycin 500 mg